A detailed history of Gts Securities LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Gts Securities LLC holds 30,700 shares of OCGN stock, worth $26,095. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,700
Previous 23,200 32.33%
Holding current value
$26,095
Previous $35,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.98 - $1.95 $22,968 - $45,702
-23,437 Reduced 38.64%
37,211 $36,000
Q2 2024

Aug 14, 2024

SELL
$1.18 - $1.98 $12,631 - $21,195
-10,705 Reduced 15.0%
60,648 $94,000
Q1 2024

May 15, 2024

BUY
$0.5 - $1.83 $30,215 - $110,586
60,430 Added 553.24%
71,353 $117,000
Q4 2023

Feb 14, 2024

BUY
$0.36 - $0.57 $3,932 - $6,226
10,923 New
10,923 $6,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $184M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.